Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ongoing phase I/II study reveals activity of ABT-263 in lymphoid malignancies

Dec. 24, 2007

New oncolytic agents disclosed in recent patent literature

Dec. 24, 2007

Positive preclinical results of SB-939 in hematological cancer models

Dec. 24, 2007

FDA issues nonapprovable letter for Indevus' Valstar

Dec. 21, 2007

Cytopia initiates phase II trial of anticancer vascular-disrupting agent CYT-997

Dec. 21, 2007

Oxford Genome Sciences and Amgen enter collaboration for therapeutic antibodies in cancer

Dec. 21, 2007

Single-agent activity seen with perifosine in malignant gliomas

Dec. 21, 2007

Kiadis Pharma successfully completes end of phase II meeting with FDA for Reviroc

Dec. 20, 2007

Idera and Merck KGaA collaborate on development of TLR9 agonists for cancer

Dec. 20, 2007

Actelion reports preliminary data from bosentan proof-of-concept cancer study

Dec. 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...